Evidence map›Paper›PMID 39998076›Full record

ArticleToxins2025

Soluble Activin Receptor Type IIB Improves Muscle Regeneration Following

Medha Sonavane, Ali Alqallaf, Robert D Mitchell, José R Almeida, Soheil Gilabadi, Nicholas J Richards, Sodiq Adeyemi, Jarred Williams, Olli Ritvos, Sakthivel Vaiyapuri and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Medha SonavaneSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.
Ali AlqallafSchool of Biological Sciences, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0003-0956-9247
Robert D MitchellMicregen Ltd., Thames Valley Science Park, Reading RG2 9LH, UK.
José R AlmeidaSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0002-4637-4468
Soheil GilabadiSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.
Nicholas J RichardsSchool of Biological Sciences, University of Reading, Reading RG6 6UB, UK.ORCID 0009-0000-5900-5226
Sodiq AdeyemiSchool of Biological Sciences, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0002-7664-7340
Jarred WilliamsSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0002-4647-1399
Olli RitvosDepartment of Physiology, Medicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0001-7017-6931
Sakthivel VaiyapuriSchool of Pharmacy, University of Reading, Reading RG6 6UB, UK.ORCID 0000-0002-6006-6517
Ketan PatelSchool of Biological Sciences, University of Reading, Reading RG6 6UB, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viper bite envenoming often results in prominent skeletal muscle damage. According to our previous studies, the prolonged presence of

Indexed as

Activin Receptors, Type IICrotalid VenomsMuscle, SkeletalRegenerationAnimalsCrotalusFibrosisMaleMiceMice, Inbred C57BLMyostatinVenomous SnakesActivin Receptors, Type IIactivin receptor type II-BCrotalid VenomsMyostatinCrotalus atroxfibrosis and muscle regenerationmyonecrosissoluble activin receptor type IIBvenom

Identifiers

PMID39998076
PMCPMC11861606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.